Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-46 PET/CT for Staging Ovarian Cancer
NCT05903807Phase 2Terminated
- Sponsor
- Aalborg University Hospital
- Start
- Nov 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in ovarian cancer, sponsored by Aalborg University Hospital. Started Nov 2023; status: terminated.
02
Drugs
68Ga FAPI-46
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05903807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903807.